(a) | by inserting, immediately below the item “Alcuronium; its salts”, the following item : |
(b) | by inserting, immediately below the item “Barbituric acid; its salts; derivatives of barbituric acid; their salts; compounds of barbituric acid, its salts; its derivatives, their salts, with any other substance”, the following items: |
(c) | by inserting, immediately below the item “Cephradine”, the following item: “Cerivastatin; its salts”; |
|
|
(d) | by inserting, immediately below the item “Flecainide; its salts”, the following item: |
(e) | by inserting, immediately below the item “Ifosfamide”, the following item: |
(f) | by inserting, immediately below the item “Imipramine; its salts”, the following item: |
(g) | by inserting, immediately below the item “Nefopam; its salts”, the following item: “Nelfinavir; its salts; its esters; their salts”; |
|
|
(h) | by inserting, immediately below the item “Netilmicin; its salts; its esters; their salts”, the following item: |
(i) | by inserting, immediately below the item “Nomegestrol; its salts; its esters; their salts”, the following item: “Nometasone; its salts; its esters; their salts”; |
|
|
(j) | by inserting, immediately below the item “Oleandomycin; its salts; its esters; their salts”, the following item: |
(k) | by inserting, immediately below the item “Rituximab”, the following item: “Rivastigmine; its salts; its esters; their salts”; and |
|
|
(l) | by inserting, immediately below the item “Yohimba, alkaloids of; its quarternary compounds; their salts”, the following item: |